Articles tagged "Kidney transplantation"

2017 American Transplant Congress
Adjuvant Chemotherapy with Gemcitabine Plus Cisplatin for Kidney Transplant Patients with Transitional Cell Carcinoma.
Z. Wang, J. Lin, Y. Zhu, J. Zhang, J. Xiao, Y. Guo, Y. Tian.
Urology, Beijing Friendship Hospital, Beijing, China
Background: The purpose of this study was to evaluate the effects and safety of adjuvant chemotherapy with gemcitabine plus cisplatin in kidney transplant patients with…
2017 American Transplant Congress
Urinary Concentration Ability in Kidney Transplant Patients as Predictor for CKD.
P. Garcia-Garcia,¹ A. Jarque,¹ A. Rivero,¹ A. Rodriguez,¹ J. Gonzalez Posadas,¹ M. Macia,¹ V. Garcia Nieto,² J. Navarro.¹
¹Nephrology Service, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; ²Pediatric Nephrology Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
Urinary concentration is the result of a complex glomerulotubular mechanism, which culpits with the stimulation of aquaporins at the collector tubule, in response to vasopressin…
2017 American Transplant Congress
Potential Barriers Hindering Non-Directed (Altruistic) Living Kidney Donors from Donating Their Kidneys.
A. Maghen,¹ L. Kwan,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² S. Maliski,³ J. Veale.
¹Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; ²Oregon Health and Science University, Portland, OR; ³University of Kansas Medical Center School of Nursing, Kansas City, KS
A. While non-directed kidney donation in the United States is a growing concept that demonstrates the next level of altruism in the U.S., there are…
2017 American Transplant Congress
Activation of Inflammation Amplifier in Kidney Graft and Urinary Biomarker for Chronic Rejection.
H. Higuchi,^1,2 D. Iwami,¹ K. Hotta,¹ N. Shinohara,¹ M. Murakami.²
¹Hokkaido University, Renal and Genitourinary Surgery, Sapporo, Hokkaido, Japan; ²Hokkaido University, Molecular Neuroimmunology, Institute of Genetic Medicine, Graduate School of Medicine, Sapporo, Hokkaido, Japan
[Introduction and Objective] Inflammation amplifier (IA), a local chemokine inducer in non-immune cells is induced by simultaneous activation of NFκB and STATs (IL-17, TNFα, and…
2017 American Transplant Congress
Comparison of Long Term Survival Outcomes for Everolimus (EVR) vs. Mycophenolic Acid (MPA) Immunosuppressive Regimens Post Kidney Transplant.
D. Cibrik,¹ W. Irish,² K. McCague,³ D. Patel,³ H. Tedesco.⁴
¹University of Michigan, Ann Arbor, MI; ²CTI Clinical Trial and Consulting Services, Raleigh, NC; ³Novartis Pharmaceuticals Corporation, East Hanover, NJ; ⁴Hospital do Rim-Escola Paulista de Medicina UNIFESP, Sao Paulo, Brazil
In the US, MPA in combination with calcineurin inhibitors (CNI, tacrolimus [TAC] or cyclosporine A [CsA]) is the most commonly used maintenance immunosuppressive therapy post…
2017 American Transplant Congress
Anti-CD25mAb Sparing Immunosuppressive Regimen Suppressed Recurrence of Post-Transplant Focal Segmental Glomerular Sclerosis- A Single Center Experience.
H. Harada, Y. Wada, N. Fukuzawa.
Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan
INTRODUCTION: The rate of recurrence of primary focal segmental glomerular sclerosis (FSGS) is problematic, because it often results in very early serious urinary protein secretion…
2017 American Transplant Congress
Soluble Human Leukocyte Antigen-G Levels and Prolonged Allograft Survival: A Demographic Analysis.
C. Callaway,¹ A. Ajith,² V. Portik-Dobos,² P. Best,³ C. Zayas,³ R. Kapoor,³ A. Horuzsko,² L. Mulloy.³
¹Medical College of Georgia, Augusta University, Augusta, GA; ²Georgia Cancer Center, Augusta University, Augusta, GA; ³Section of Nephrology, Department of Medicine, Augusta University, Augusta, GA
Human leukocyte antigen-G (HLA-G) is a tolerogenic protein shown to contribute to allograft survival. Dimerized, soluble HLA-G (sHLA-Gd) has been shown to significantly prolong allograft…
2017 American Transplant Congress
No Impact of One Year of Everolimus, as Compared to MPA, in the Reversal of Left Ventricular Hypertrophy in Elderly Renal Transplant Recipients – Preliminary Data from Then Everold Study.
E. David-Neto,¹ F. Agena,¹ M. Furtado,² A. Rodriges,² J. Andrade,² F. Lemos,¹ F. Paula.¹
¹Renal Transplantation Service, Hospital das Clinicas – University of Sao Paulo School of Medicine, Sao Paulo, Brazil; ²Echocardiography Services, Hospital das Clinicas – University of Sao Paulo School of Medicine, Sao Paulo, Brazil
It has been suggested that mTor inhibitors may contribute to the reversal of myocardial hypertrophy after transplantation possibly due to its biological effects like enhanced…
2017 American Transplant Congress
Racial and Ethnic Disparities in Renal Replacement Therapy in Pediatric and Young Adult Population with End Stage Renal Disease (2005-2015).
R. George,¹ M. Basu,² L. Greenbaum,¹ A. Kirk,^2,3 N. Kutner,⁴ R. Patzer.^2,5
¹Pediatric Nephrology, Emory University, Atlanta, GA; ²Dept of Surgery, Emory University, Atlanta, GA; ³Dept of Surgery, Duke University, Durham, NC; ⁴USRDS Rehabilitation, QoL Special Studies Center, Atlanta, GA; ⁵Dept of Epidemiology, Rollins School of Public Health, Atlanta, GA
In the last decade, few studies have examined racial/ethnic disparities in the choice of renal replacement therapy (RRT) among children with End Stage Renal Disease…
2017 American Transplant Congress
Sensitized KPD Pairs Take Longer to Find Matches.
C. Holscher,¹ E. Chow,¹ C. Purcell,² M. Ronin,² J. Garonzik-Wang,¹ A. Massie,¹ S. Gentry,³ D. Segev.¹
¹Johns Hopkins University, Baltimore; ²National Kidney Registry, New York; ³US Naval Academy, Annapolis
Kidney paired donation (KPD) can facilitate living donor transplantation for candidates with an incompatible donor, but it is unclear how sensitization or blood type affects…